Supplementary Table S2: Laboratory Abnormalities from FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid Leukemia
Year: 2023
Type: supplementary-materials
Authors: Kelly J. Norsworthy, Kunthel By, Sriram Subramaniam, Luning Zhuang, Pedro L. Del Valle, Donna Przepiorka, Yuan-Li Shen, Christopher M. Sheth, Chao Liu, Ruby Leong, Kirsten B. Goldberg, Ann T. Farrell, Richard Pazdur
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361887851